Runx1 transcription factor modulates opioid analgesia and withdrawal in humans and rodents
Neuron · 2026
DOI: 10.1016/j.neuron.2025.11.018 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuron, 2026. Verfasst von Heather Leduc-Pessah und 39 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Veterinary Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada; Department of Physiology & Pharmacology, Cumming School of Medici…. Hauptthemen laut MEDLINE: Analgesics, Opioid, Substance Withdrawal Syndrome, Core Binding Factor Alpha 2 Subunit. Die Arbeit nennt 115 Literaturangaben. Gefördert von: Japan Agency for Medical Research and Development, Natural Sciences and Engineering Research Council of Canada, Canadian Institutes of Health Research.
Abstract (Originalsprache)
Opioid analgesia and adverse outcomes vary across individuals. We show that runt-related transcription factor 1 (Runx1) modulates the microglial transcriptome and is a genetic determinant of opioid antinociceptive responses and withdrawal. In mice, Runx1 deletion in microglia produces distinct ultrastructural and transcriptomic signatures, reducing morphine potency despite no prior opioid exposure. These mice also require greater post-operative morphine and display exacerbated morphine-induced hyperalgesia and withdrawal. Single-cell RNA sequencing (scRNA-seq) and chromatin immunoprecipitation sequencing (ChIP-seq) analyses reveal a unique microglial state, with Runx1 regulating inflammatory signaling and key microglial functions. In humans, association analyses link RUNX1 variants to inter-individual differences in perioperative opioid requirement and withdrawal severity. Identifying RUNX1 susceptibility genotypes may be important for understanding individual variability in opioid responses, with potential relevance for future personalized approaches.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Veterinary Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada; Department of Physiology & Pharmacology, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada; Hotchkiss Brai…
- Faculty of Veterinary Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada.
- Addictive Substance Project, Tokyo Metropolitan Institute of Medical Science, 2-1-6, Kamikitazawa, Setagaya-ku, Tokyo 156-8506, Japan; Department of Neuropsychopharmacology, National Institute of Mental Health, National…
- School of Medical Sciences, University of Victoria, Victoria, BC, Canada.
- Department of Physiology & Pharmacology, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada; Hotchkiss Brain Institute, University of Calgary, Calgary, AB T2N 4N1, Canada; Snyder Institute fo…
- CERVO Brain Research Centre, Québec Mental Health Institute, Graduate program in Neuroscience, Université Laval University, Department of Psychiatry and Neuroscience, Department of Anesthesiology & Intensive Care, Unive…
Förderung
- Japan Agency for Medical Research and Development
- Natural Sciences and Engineering Research Council of Canada
- Canadian Institutes of Health Research
- Canada Research Chairs Program
- Wallonie-Bruxelles International
- Japan Society for the Promotion of Science
- ALS Society of Canada
- Killam Trusts
Zitieren
APA
Leduc-Pessah, H., McAllister, B. B., Sinha, S., Stokes-Heck, S., Nishizawa, D., Fan, C. Y., St-Pierre, M. K., Bradaia, A., Defaye, M., Burma, N. E., Damblon, J., Muñoz-Pino, E., Visser, F., Dorion, M. F., Healy, L. M., Tang, Y. M., Canet-Pons, J., van den Hoogen, N. J., Zhang, Z., …, & Trang, T. (2026). Runx1 transcription factor modulates opioid analgesia and withdrawal in humans and rodents. Neuron. https://doi.org/10.1016/j.neuron.2025.11.018
Vancouver
Leduc-Pessah H, McAllister BB, Sinha S, Stokes-Heck S, Nishizawa D, Fan CY, et al. Runx1 transcription factor modulates opioid analgesia and withdrawal in humans and rodents. Neuron. 2026. doi:10.1016/j.neuron.2025.11.018
BibTeX
@article{LeducPessah2026,
author = {Leduc-Pessah, Heather and McAllister, Brendan B and Sinha, Sarthak and Stokes-Heck, Sierra and Nishizawa, Daisuke and Fan, Churmy Y and St-Pierre, Marie-Kim and Bradaia, Amyaouch and Defaye, Manon and Burma, Nicole E and Damblon, Jonathan and Muñoz-Pino, Einer and Visser, Frank and Dorion, Marie-France and Healy, Luke M and Tang, Ye Man and Canet-Pons, Julia and van den Hoogen, Nynke J and Zhang, Zizhen and Antunes, Flavia T T and Piscopo, Valerio E C and Medina, Margaret and Fukuda, Ken-Ichi and Ichinohe, Tatsuya and Nagashima, Makoto and Hayashida, Masakazu and Johnson, Emma and Agrawal, Arpana and Degenhardt, Louisa and Martin, Nicholas G and Zamponi, Gerald W and Nelson, Elliot C and Altier, Christophe and Tremblay, Marie-Eve and Bousman, Chad and Stifani, Stefano and De Koninck, Yves and Ikeda, Kazutaka and Biernaskie, Jeff and Trang, Tuan},
title = {Runx1 transcription factor modulates opioid analgesia and withdrawal in humans and rodents},
journal = {Neuron},
year = {2026},
doi = {10.1016/j.neuron.2025.11.018}
}
EUVIMED